In Silico Exploration of Metabolically Active Peptides as Potential Therapeutic Agents against Amyotrophic Lateral Sclerosis

被引:4
|
作者
Fatoki, Toluwase Hezekiah [1 ]
Chukwuejim, Stanley [1 ,2 ]
Udenigwe, Chibuike C. [3 ,4 ]
Aluko, Rotimi E. [2 ,5 ]
机构
[1] Fed Univ Oye Ekiti, Dept Biochem, PMB 373, Oye 371104, Nigeria
[2] Univ Manitoba, Dept Food & Human Nutr Sci, Winnipeg, MB R3T 2N2, Canada
[3] Univ Ottawa, Fac Hlth Sci, Sch Nutr Sci, Ottawa, ON K1H 8M5, Canada
[4] Univ Ottawa, Fac Sci, Dept Chem & Biomol Sci, Ottawa, ON K1N 6N5, Canada
[5] Univ Manitoba, Richardson Ctr Food Technol & Res, Winnipeg, MB R3T 2N2, Canada
关键词
amyotrophic lateral sclerosis; ALS; associated genes; hydrolysate peptides; pharmacokinetics; target prediction; metabolic; supplements; molecular docking; TRANSGENIC MOUSE MODEL; PROTECTS MOTOR-NEURONS; BLOOD-BRAIN-BARRIER; SPINAL-CORD; APOPTOSIS PROTEIN; CYCLOOXYGENASE-2; INHIBITION; GENE; XIAP; CLEAVAGE;
D O I
10.3390/ijms24065828
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Amyotrophic lateral sclerosis (ALS) is regarded as a fatal neurodegenerative disease that is featured by progressive damage of the upper and lower motor neurons. To date, over 45 genes have been found to be connected with ALS pathology. The aim of this work was to computationally identify unique sets of protein hydrolysate peptides that could serve as therapeutic agents against ALS. Computational methods which include target prediction, protein-protein interaction, and peptide-protein molecular docking were used. The results showed that the network of critical ALS-associated genes consists of ATG16L2, SCFD1, VAC15, VEGFA, KEAP1, KIF5A, FIG4, TUBA4A, SIGMAR1, SETX, ANXA11, HNRNPL, NEK1, C9orf72, VCP, RPSA, ATP5B, and SOD1 together with predicted kinases such as AKT1, CDK4, DNAPK, MAPK14, and ERK2 in addition to transcription factors such as MYC, RELA, ZMIZ1, EGR1, TRIM28, and FOXA2. The identified molecular targets of the peptides that support multi-metabolic components in ALS pathogenesis include cyclooxygenase-2, angiotensin I-converting enzyme, dipeptidyl peptidase IV, X-linked inhibitor of apoptosis protein 3, and endothelin receptor ET-A. Overall, the results showed that AGL, APL, AVK, IIW, PVI, and VAY peptides are promising candidates for further study. Future work would be needed to validate the therapeutic properties of these hydrolysate peptides by in vitro and in vivo approaches.
引用
收藏
页数:22
相关论文
共 50 条
  • [31] Inflammatory checkpoints in amyotrophic lateral sclerosis: From biomarkers to therapeutic targets
    Jiang, Zongzhi
    Wang, Ziyi
    Wei, Xiaojing
    Yu, Xue-Fan
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [32] Involvement of Immune Response in the Pathogenesis of Amyotrophic Lateral Sclerosis: A Therapeutic Opportunity?
    Calvo, A.
    Moglia, C.
    Balma, M.
    Chio, A.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (03) : 325 - 330
  • [33] New insights into Wnt signaling alterations in amyotrophic lateral sclerosis: a potential therapeutic target?
    Gonzalez-Fernandez, Carlos
    Gonzalez, Pau
    Javier Rodriguez, Francisco
    NEURAL REGENERATION RESEARCH, 2020, 15 (09) : 1580 - 1589
  • [34] Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation
    Faravelli, Irene
    Riboldi, Giulietta
    Nizzardo, Monica
    Simone, Chiara
    Zanetta, Chiara
    Bresolin, Nereo
    Comi, Giacomo P.
    Corti, Stefania
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2014, 71 (17) : 3257 - 3268
  • [35] Discovery of Mitophagy Inhibitors with Therapeutic Potential in Different Familial Amyotrophic Lateral Sclerosis Mutations
    Maestro, Ines
    de la Ballina, Laura R.
    Porras, Gracia
    Corrochano, Silvia
    De Lago, Eva
    Simonsen, Anne
    Boya, Patricia
    Martinez, Ana
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (20)
  • [36] The Role and Therapeutic Potential of the Integrated Stress Response in Amyotrophic Lateral Sclerosis
    Marlin, Elias
    Viu-Idocin, Cristina
    Arrasate, Montserrat
    Aragon, Tomas
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (14)
  • [37] Diagnosis, Pathogenesis and Therapeutic Targets in Amyotrophic Lateral Sclerosis
    Costa, Julia
    Gomes, Catarina
    de Carvalho, Mamede
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (06) : 764 - 778
  • [38] Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting
    Amin, Azin
    Perera, Nirma D.
    Beart, Philip M.
    Turner, Bradley J.
    Shabanpoor, Fazel
    CELLS, 2020, 9 (11) : 1 - 30
  • [39] Boosting Mitochondrial Potential: An Imperative Therapeutic Intervention in Amyotrophic Lateral Sclerosis
    Dhasmana, Swati
    Dhasmana, Anupam
    Kotnala, Sudhir
    Mangtani, Varsha
    Narula, Acharan S.
    Haque, Shafiul
    Jaggi, Meena
    Yallapu, Murali M.
    Chauhan, Subhash C.
    CURRENT NEUROPHARMACOLOGY, 2023, 21 (05) : 1117 - 1138
  • [40] Putative Roles and Therapeutic Potential of the Chaperone System in Amyotrophic Lateral Sclerosis and Multiple Sclerosis
    Noori, Leila
    Saqagandomabadi, Vahid
    Di Felice, Valentina
    David, Sabrina
    Bavisotto, Celeste Caruso
    Bucchieri, Fabio
    Cappello, Francesco
    de Macario, Everly Conway
    Macario, Alberto J. L.
    Scalia, Federica
    CELLS, 2024, 13 (03)